Incyte (INCY) Announces Data on Monjuvi, FDA Approval for GVHD Drug
ZacksIncyte???s (INCY) late-stage study on tafasitamab for patients with relapsed or refractory follicular lymphoma meets its goal. FDA approves axatilimab for the treatment of chronic graft-versus-host disease.